Evidence map›Paper›PMID 41121433›Full record

ArticleJournal of medical case reports2025

Sinonasal mucosal melanoma in an elderly patient: a case report.

Edwin Liwa, Gilbert Nkya, Angela Pallangyo, Patrick Amsi, Jeremia Pyuza, Furaha Kasyupa, Deardiana Gladstone, Alex Mremi, Sylvia Moshi, Glory Makupa and 4 more

Abstract readCase Reports
In one paragraph

Article in Journal of medical case reports, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

14 authors.

Edwin LiwaArusha Lutheran Medical Centre, Arusha, Tanzania. liwaedu@yahoo.com.ORCID http://orcid.org/0000-0001-5664-9915
Gilbert NkyaKilimanjaro Christian Medical Centre, Kilimanjaro, Tanzania.
Angela PallangyoKilimanjaro Christian Medical Centre, Kilimanjaro, Tanzania.
Patrick AmsiKilimanjaro Christian Medical Centre, Kilimanjaro, Tanzania.
Jeremia PyuzaKilimanjaro Christian Medical Centre, Kilimanjaro, Tanzania.
Furaha KasyupaKilimanjaro Christian Medical Centre, Kilimanjaro, Tanzania.
Deardiana GladstoneKilimanjaro Christian Medical Centre, Kilimanjaro, Tanzania.
Alex MremiKilimanjaro Christian Medical Centre, Kilimanjaro, Tanzania.
Sylvia MoshiArusha Lutheran Medical Centre, Arusha, Tanzania.
Glory MakupaKilimanjaro Christian Medical Centre, Kilimanjaro, Tanzania.
Jabu MavundlaEswatini Nazarene Health Institutions (ENHI), Manzini, Eswatini.
Stephen GondweKilimanjaro Christian Medical Centre, Kilimanjaro, Tanzania.
Evalily MbwiloSoftMed Company Limited, Arusha, Tanzania.
Subira MatikuCatholic University of Health and Allied Sciences, Mwanza, Tanzania.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

backgroundMucosal melanoma is an aggressive Malignancy arising from melanocytes in mucosal membranes. Sinonasal mucosal melanoma accounts for approximately 1% of all melanomas and 4% of all sinonasal tumors. Unlike cutaneous melanoma, its etiology remains unclear, and it is often diagnosed at an advanced stage owing to nonspecific symptoms, leading to poor prognosis. CASE PRESENTATION: We present the case of an 80-year-old African female with nasal obstruction and recurrent epistaxis for 6 months. Clinical examination and imaging revealed an enhancing soft tissue sinonasal lesion with osseous destruction. Functional endoscopic sinus surgery was performed for tumor debulking, and histopathological analysis confirmed mucosal melanoma with immunohistochemical positivity for HMB45. Despite surgical intervention, the patient was placed on home care owing to the aggressive nature of the disease and limited treatment options. Imaging confirmed local invasion but no distant metastases.

conclusionSinonasal mucosal melanoma is an aggressive entity requiring early diagnosis and multimodal management. Surgical resection remains the primary treatment, but novel therapeutic strategies, including immune checkpoint inhibitors, are needed to improve patient outcomes.

Indexed as

MelanomaNasal MucosaNose NeoplasmsParanasal Sinus NeoplasmsAged, 80 and overEndoscopyEpistaxisFemaleHumansNasal ObstructionTomography, X-Ray ComputedAggressive malignancyHead and neck cancerMelanocytic neoplasmsMucosal melanomaSinonasal

Identifiers

PMID41121433
PMCPMC12538789

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.